Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice

Author： Xiang M. Zaccone P. Di Marco R. Magro G. Di Mauro M. Beltrami B. Meroni P. Nicoletti F.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.367, Iss.2, 1999-02, pp. : 399-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminoguanidine prevents concanavalin A-induced hepatitis in mice

By Okamoto T. Masuda Y. Kawasaki T. Shinohara M. Matsuzaki K.

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Suppression of cytochrome P450 gene expression in the livers of mice with concanavalin A-induced hepatitis

By Okamoto T.

European Journal of Pharmacology, Vol. 394, Iss. 1, 2000-04 ,pp. : 157-161

Elsevier

Access to resources Recommend Favorite

Impaired NK cell cytotoxicity by high level of interferon-γ in concanavalin A-induced hepatitis

By Dong Zhongjun Zhang Cai Wei Haiming Sun Rui Tian Zhigang

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 11, 2005-11 ,pp. : 1045-1053

NRC Research Press

Access to resources Recommend Favorite

Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model

By Kuzuhara H. Nishiyama S. Minowa N. Sasaki K. Omoto S.

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram

By Iyo M. Ying B. Hashimoto K. Inada T. Fukui S.

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite